已收盤 11-06 16:00:00 美东时间
-7.080
-18.72%
Interface shares are trading lower after the company reported mixed Q3 financial results and cut its FY26 sales guidance below estimates. Also, the company lowered its FY26 net sales guidance.
11-06 22:03
Interface (NASDAQ:TILE) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.62 by 9.68 percent. This is a 11.48 percent increase over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $366.700 million which ...
11-06 18:31
Interface (NASDAQ:TILE) lowers FY2026 sales outlook from $1.455 billion-$1.485 billion to $1.440 billion-$1.455 billion vs $1.474 billion estimate.
11-06 18:30
11月3日,Interface Inc.(TILE)收涨4.37%,报38.42美元,成交额1644.71万美元,市值22.21亿美元。 行情数据 • 开盘价...
11-03 06:23
10月27日,Interface Inc.(TILE)收涨0.08%,报36.45美元,成交额1634.52万美元,市值21.07亿美元。 行情数据 • 开盘价...
10-27 05:25
ProKidney Corp. will present eight abstracts, including one oral presentation, at the American Society of Nephrology’s Kidney Week 2026 in Denver. The abstracts highlight rilparencel's multifactorial mechanism of action, safety profile, and kidney function stabilization in advanced CKD and type 2 diabetes. The oral presentation focuses on graft-adjacent remodeling and vascular integrity in a CKD model. Other posters cover metabolic transitioning,...
10-22 12:00
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:27
BEIJING, Oct. 05, 2026 – Niu Technologies reported Q3 2026 sales of 537,457 units, up 15% year-over-year, with China market sales at 490,406 units (9% YoY growth) and international markets at 47,051 units. NIU's AIOS platform won a Red Dot Award for its user experience design. The company plans to integrate advanced technologies to enhance product offerings and expand its global presence.
10-05 08:00
ProKidney Corp. will present eight abstracts, including one oral presentation, at the American Society of Nephrology’s Kidney Week 2026. The abstracts highlight rilparencel’s multifactorial mechanism of action in chronic kidney disease (CKD), with seven non-clinical studies showing evidence of oxidative damage attenuation, metabolic dysregulation, and pro-inflammatory signaling reduction. A clinical abstract presents Phase 2 data indicating safet...
10-02 13:00
Microchip Technology introduces the PAC1761 and PAC1861 families of 65V digital power monitors, designed for 48V power architectures in automotive, AI/data center, networking, and industrial systems. These devices provide accumulated energy data, high-voltage measurement headroom, and spike protection to enhance system efficiency and resilience. Features include programmable alerts, step-limit detection, and configurable thresholds for proactive ...
09-24 11:14